Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
Androgen-deprivation therapy (ADT) is standard treatment for locally advanced or metastatic prostate cancer (PCa). Many patients develop castration resistance (castration-resistant PCa [CRPC]) after approximately 2-3 yr, with a poor prognosis. The molecular mechanisms underlying CRPC progression are...
Glavni autori: | , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
2014
|